Plain-English translation of NCT06701084 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is looking for the genetic causes of seizures that start in babies under one year old. Researchers will perform genetic sequencing on your baby's blood to try to identify what is causing the seizures. If they find a genetic cause, the results will be shared with your family and your baby's doctors to help guide care.
Most babies with early-onset seizures likely have a genetic cause, but doctors don't currently have answers for most families. By discovering the genetic reasons behind these seizures, researchers hope to develop better, more personalized treatments and improve outcomes for infants and their families.
You likely qualify if…
You likely don't qualify if…
Your baby will undergo genetic sequencing through a blood sample, which researchers will analyze to look for genetic causes of the seizures. You and your family will be followed until your child is 2.5 years old, during which time you'll share information about how the genetic diagnosis has affected your baby's treatment and your family's wellbeing through follow-up visits and conversations with the research team.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Boston Children's Hospital
Enrollment target
~600 participants
Started
September 2021
Primary completion
November 2029
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Beth R Sheidley, MS
Boston Children's Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.